Bernfield M,Gtte M,Park PW,et al.Functions of cell surface heparan sulfate proteoglycans[J]. Annu Rev Biochem,1999,68:729-777.
[2]
Oh JH,Kim JH.Syndecan-1 enhances the endometrial cancer invasion by modu lating matrix metalloproteinase-9 expression through nuclear factor kappaB.[J ]. Gynecol Oncol,2009,114(3):509-515.
[3]
Choi DS,Kim JH. Syndecan-1,a key regulator of cell viability in endometrial cancer. Int J Cancer[J].2007,121(4):741-750.
[4]
Miturski R,Jalkanen M. Immunohistochemical expression of syndecan-1 inhuman endometrial cancer cells[J]. Int J Mol Med,1998,2(4):397-401.
[5]
Hasengaowa,Kodama J. Prognostic significance of syndecan-1 expression in human endometrial cancer[J]. Ann Oncol,2005,16(7):1109-1115.
[6]
Margulis A,Zhang W,Alt-Holand A,et al.Loss of intercellular adhesion activates a transition from low-to high-grade human squamous cell carcinoma[J] .Int J Cancer,2006,118(4):821-831.
[7]
乐杰.妇产科学[M].7版.北京:人民卫生出版社,2008:272.
[8]
Loussouarn D,Campion L,et al. Prognostic impact of syndecan-1 expressionin invasive ductal breast carcinomas[J]. Br J Cancer,2008,98(12):1993-1998.
[9]
Kainulaine V,Nelimarkka L,Jarvelainen H,et al.Suppress-ion of syndecan- 1 expression in endothelial cells by tumor necrosis factor-alpha[J].J Biol Ch em,1996,271(31):18759-18766.
[10]
Pap Z,Pávai Z. An immunohistochemical study of colon adenomas an d carcinomas:E-cadherin,Syndecan-1,Ets-1[J].Pathol Oncol Res,2009,15(4) :579-87.
[11]
Ohashi M,Kusumi T. Expression of syndecan-1 and E-cadherin is inversely correlated with poor patient's prognosis and recurrent status of extrahepat ic bile duct carcinoma[J]. Biomed Res,2009,30(2):79-86.
